Analyst Consensus ?
ConsensusBuy51 ratings
Bullish2854.9%
Neutral2141.2%
Bearish23.9%
Fifth Third Bancorp · FITB · FY2026 Q2 · Calendar Q3 2026
Fifth Third Posts Q2 Beat as Comerica Integration Accelerates
Fifth Third Bancorp delivered Q2 2026 results that beat revenue estimates while narrowly missing EPS consensus, with the Comerica merger integration running ahead of schedule. Management raised full-year net interest income and non-interest income guidance while lowering expense guidance, citing $850 million in expense synergies already in sight. The deposit franchise expanded rapidly in the Southeast and Southwest, fee revenue momentum continued across payments and wealth management, and the company reiterated plans to resume share repurchases in H2 2026. Despite a soft market reaction on the day, the underlying franchise trajectory strengthened from Q1, with bullish sentiment improving from 78 to 82 and guidance moving from maintained to raised.
Reported Before market openNYSEFinancial Services
$52.38B market cap
100quality score
Company context
Snapshot as of publicationFifth Third Bancorp operates as the bank holding company for Fifth Third Bank, National Association that provides a range of financial products and services in the United States. It operates through three segments: Commercial Banking, Consumer and Small Business Banking, and Wealth and Asset Management. The Commercial Banking segment offers credit intermediation, cash management, and financial services; lending and depository products; and cash management, foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers.…
Earnings scorecard
Reported versus consensus
Reported EPS
$0.83
Consensus $1
EPS surprise
-0.8%
Reported versus consensus
Reported revenue
$3.26B
Consensus $3.24B
Revenue surprise
+0.5%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$56.57Current
$4.5Low
$50.7Average
$67High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 21, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 20, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jul 20, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 20, 2026 |
| UBS | Buy | Buy | Maintain | Jul 7, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 6, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 29, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jun 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Jun 8, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 20, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Mar 30, 2026 |
| TD Cowen | Buy | Buy | Maintain | Feb 3, 2026 |
| Stephens & Co. | Overweight | Equal Weight | Upgrade | Oct 14, 2025 |
| Argus Research | Buy | Buy | Maintain | Jul 22, 2024 |
| Jefferies | Buy | Buy | Maintain | Jul 3, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | May 31, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 18, 2023 |
| Wedbush | Outperform | Outperform | Maintain | Jul 21, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Sep 12, 2022 |
| CFRA | Buy | Buy | Maintain | Apr 22, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| Odeon Capital | Hold | Hold | Maintain | Dec 6, 2019 |
| Raymond James | Outperform | Outperform | Maintain | Oct 23, 2019 |
| Bank of America | Buy | Buy | Maintain | Oct 23, 2019 |
| BMO Capital | Market Perform | Market Perform | Maintain | Apr 25, 2019 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Apr 4, 2019 |
| Argus | Buy | Buy | Maintain | Jun 14, 2018 |
| Macquarie | Underperform | Neutral | Downgrade | Nov 17, 2017 |
| Compass Point | Buy | Neutral | Upgrade | Mar 29, 2017 |
| Hilliard Lyons | Neutral | Underperform | Upgrade | Jan 25, 2017 |
| Bernstein | Market Perform | Outperform | Downgrade | Nov 16, 2016 |
| CLSA | Outperform | Outperform | Maintain | Sep 23, 2016 |
| Oppenheimer | Perform | Outperform | Downgrade | Jul 6, 2016 |
| Susquehanna | Neutral | Positive | Downgrade | Jun 7, 2016 |
| Sterne Agee CRT | Neutral | Buy | Downgrade | Apr 6, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Apr 6, 2016 |
| Credit Suisse | Underperform | Underperform | Maintain | Mar 10, 2016 |
| PiperJaffray | Neutral | Neutral | Maintain | Nov 23, 2015 |
| Guggenheim | Neutral | Buy | Downgrade | Oct 21, 2015 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Jun 29, 2015 |
| FBR Capital | Market Perform | Outperform | Downgrade | Jan 22, 2015 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Dec 16, 2013 |
| Rafferty Capital | Hold | Buy | Downgrade | Nov 6, 2013 |
| Rafferty | Hold | Buy | Downgrade | Nov 6, 2013 |
| ISI Group | Buy | Buy | Maintain | Oct 7, 2013 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Feb 11, 2013 |
| Stifel | Hold | Buy | Downgrade | Feb 11, 2013 |
| Miller Tabak | Strong Buy | Strong Buy | Maintain | Aug 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $56.57. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| D.A. Davidson | Analyst unavailable | $65 | $57.96 | +14.9% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $62 | $58.01 | +9.6% | Jul 20, 2026 |
| UBS | Erika Najarian | $65 | $58.27 | +14.9% | Jul 7, 2026 |
| Evercore ISI | Analyst unavailable | $60 | $57.72 | +6.1% | Jul 6, 2026 |
| Wells Fargo | Analyst unavailable | $67 | $57.16 | +18.4% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $58 | $52.01 | +2.5% | Jun 8, 2026 |
| Truist Financial | Analyst unavailable | $57 | $51.05 | +0.8% | Apr 21, 2026 |
| Evercore ISI | Analyst unavailable | $53 | $51.68 | -6.3% | Apr 21, 2026 |
| Barclays | Jason Goldberg | $63 | $50.34 | +11.4% | Apr 20, 2026 |
| Evercore ISI | Analyst unavailable | $57 | $53.48 | +0.8% | Feb 5, 2026 |
| UBS | Erika Najarian | $59 | $54.57 | +4.3% | Feb 4, 2026 |
| Truist Financial | Analyst unavailable | $60 | $50.23 | +6.1% | Jan 26, 2026 |
| D.A. Davidson | Peter Winter | $58 | $50.19 | +2.5% | Jan 26, 2026 |
| RBC Capital | Analyst unavailable | $57 | $51.62 | +0.8% | Jan 21, 2026 |
| Wolfe Research | Analyst unavailable | $55 | $49.1 | -2.8% | Jan 7, 2026 |
| Evercore ISI | John Pancari | $52 | $49.46 | -8.1% | Jan 6, 2026 |
| UBS | Analyst unavailable | $57 | $48.62 | +0.8% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $61 | $47.71 | +7.8% | Jan 5, 2026 |
| Truist Financial | Brian Foran | $55 | $48.1 | -2.8% | Dec 22, 2025 |
| Piper Sandler | Analyst unavailable | $50 | $45.17 | -11.6% | Dec 10, 2025 |
| Stephens | Analyst unavailable | $52 | $42.2 | -8.1% | Oct 14, 2025 |
| D.A. Davidson | Analyst unavailable | $52 | $44.03 | -8.1% | Oct 8, 2025 |
| UBS | Analyst unavailable | $45 | $43.67 | -20.5% | Oct 7, 2025 |
| Morgan Stanley | Manan Gosalia | $60 | $43.79 | +6.1% | Oct 7, 2025 |
| Evercore ISI | Analyst unavailable | $49 | $45.4 | -13.4% | Sep 30, 2025 |
| Morgan Stanley | Manan Gosalia | $56 | $45.43 | -1.0% | Sep 29, 2025 |
| D.A. Davidson | Peter Winter | $47 | $39.58 | -16.9% | Jun 9, 2025 |
| D.A. Davidson | Peter Winter | $46 | $43.37 | -18.7% | Oct 21, 2024 |
| Citigroup | Keith Horowitz | $43 | $44.67 | -24.0% | Oct 21, 2024 |
| Piper Sandler | Scott Siefers | $48 | $41.76 | -15.1% | Oct 3, 2024 |
| Stephens | Terry McEvoy | $42 | $39.8 | -25.8% | Sep 11, 2024 |
| Piper Sandler | Scott Siefers | $45 | $42.34 | -20.5% | Sep 3, 2024 |
| Argus Research | Stephen Biggar | $46 | $40.42 | -18.7% | Jul 22, 2024 |
| RBC Capital | Gerard Cassidy | $43 | $40.99 | -24.0% | Jul 22, 2024 |
| D.A. Davidson | Peter Winter | $42 | $40.99 | -25.8% | Jul 22, 2024 |
| Wells Fargo | Mike Mayo | $42 | $35.28 | -25.8% | Jun 12, 2024 |
| Wolfe Research | Bill Carcache | $43 | $36.75 | -24.0% | May 31, 2024 |
| UBS | Erika Najarian | $39 | $36.05 | -31.1% | Apr 4, 2024 |
| Robert W. Baird | David George | $32 | $37.21 | -43.4% | Apr 1, 2024 |
| Stephens | Terry McEvoy | $41 | $35.43 | -27.5% | Mar 19, 2024 |
| Raymond James | David Long | $4.5 | $51.41 | -92.0% | Jan 19, 2024 |
| Barclays | Analyst unavailable | $47 | $32.81 | -16.9% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $36 | $31.94 | -36.4% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $37 | $33.28 | -34.6% | Dec 5, 2022 |
| Morgan Stanley | Analyst unavailable | $43 | $33.96 | -24.0% | Jul 12, 2022 |
| UBS | Erika Najarian | $56 | $48.88 | -1.0% | Jan 12, 2022 |
| Barclays | Jason Goldberg | $53 | $44.38 | -6.3% | Jan 3, 2022 |
| Argus Research | Stephen Biggar | $49 | $44.98 | -13.4% | Oct 20, 2021 |
| Stephens | Terry McEvoy | $48 | $44.98 | -15.1% | Oct 20, 2021 |
| KBW | David Konrad | $42 | $36.57 | -25.8% | Jul 6, 2021 |
Track every rating change on FITB the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session close
Stock move
-2.3%
Event window
SPY move
-1.0%
Same window
Abnormal move
-1.3%
Stock minus SPY
Volume
1.6×
Versus trailing sessions
Subsequent drift
-2.5%
Up to 20 sessions
FITBSPY benchmark
Follow FITB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Q2 revenue of $3.26 billion edged out the $3.244 billion consensus, while EPS of $0.83 narrowly missed the $0.837 estimate. Versus Q1, where full-year guidance was maintained, management raised full-year NII and non-interest income guidance and lowered expense guidance, targeting a 53% efficiency ratio for 2027. The Comerica systems conversion is on track for Labor Day weekend, with expense synergies already exceeding expectations. Checking households in the Southwest grew 4% sequentially. The Direct Express platform shipped its first cards to 66,000 new beneficiaries, and AI tooling generated over 1 million prompts in June with 45% new-code acceptance.
Guidance delta
Management raised full-year guidance for both net interest income and non-interest income while lowering expense guidance, a shift from Q1 when full-year guidance was maintained. Prior guidance ranges were NII $8.7-8.8 billion and non-interest income $4.0-4.2 billion. The company now targets a 53% efficiency ratio for 2027 and reaffirmed plans to resume quarterly share repurchases in H2 2026.
Key takeaways
- Revenue of $3.26 billion beat consensus by roughly 0.5%; EPS of $0.83 narrowly missed the $0.837 estimate.
- Comerica integration is ahead of schedule, with the systems conversion set for Labor Day weekend and expense synergies exceeding expectations.
- Deposit growth accelerated, particularly in the Southwest where checking households grew 4% sequentially.
- Full-year guidance was raised for NII and non-interest income, with expense guidance lowered and a 53% efficiency ratio target for 2027.
- Fee revenue momentum continued, driven by Newline payments, wealth and asset management, and capital markets.
Management priorities
- Complete the Comerica systems conversion over Labor Day weekend.
- Open 55 new Southeast branches for the full year and accelerate Texas and Southwest openings toward the 150-branch target.
- Scale the Direct Express platform and increase beneficiary onboarding.
- Expand AI and digital capabilities, including the Model Context Protocol and AI-powered mobile interface.
- Resume quarterly share repurchases in H2 2026 and invest remaining synergies into growth initiatives.
Related earnings events
Financial ServicesAXP · FY2026 Q2 · Calendar Q3 2026AXP Q2 2026: Platinum Card Drives 10% Revenue Growth, Full-Year Guidance RaisedAMP · FY2026 Q2 · Calendar Q3 2026Ameriprise Q2 2026: Revenue Up 13%, EPS Beats on Record AUM and AI-Driven ProductivityNDAQ · FY2026 Q2 · Calendar Q3 2026Nasdaq Q2: Revenue Up 15%, EPS Beats by 9%, Index AUM Crosses $1 Trillion
Sources
- Earnings call transcript and parsed analysis · 2026-07-17T20:05:14.572322+00:00
- FN2 earnings calendar · 2026-07-29T01:23:15.868211+00:00
- Polygon adjusted daily market bars · 2026-07-29T22:21:14.088632+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T22:21:14.086043+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.